Maitland ML - Search Results

1

Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension.

Thomeas-McEwing V, Psotka MA, Gamazon ER, Friedman P, Konkashbaev A, Kubo M, Nakamura Y, Ratain MJ, Benza RL, Cox NJ, Gomberg-Maitland MI, Maitland ML. Thomeas-McEwing V, et al. Among authors: maitland ml. Pharmacogenet Genomics. 2022 Jun 1;32(4):144-151. doi: 10.1097/FPC.0000000000000463. Epub 2022 Apr 7. Pharmacogenet Genomics. 2022. PMID: 35383711

2

Polymorphisms of adrenergic receptors and the risk of heart failure.

Maitland ML, Gomberg-Maitland M. Maitland ML, et al. N Engl J Med. 2003 Jan 30;348(5):468-70; author reply 468-70. N Engl J Med. 2003. PMID: 12557866 No abstract available.

3

Interpreting disparate responses to cancer therapy: the role of human population genetics.

Maitland ML, DiRienzo A, Ratain MJ. Maitland ML, et al. J Clin Oncol. 2006 May 10;24(14):2151-7. doi: 10.1200/JCO.2005.05.2282. J Clin Oncol. 2006. PMID: 16682733 Review.

4

TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?

Maitland ML, Vasisht K, Ratain MJ. Maitland ML, et al. Trends Pharmacol Sci. 2006 Aug;27(8):432-7. doi: 10.1016/j.tips.2006.06.007. Epub 2006 Jul 3. Trends Pharmacol Sci. 2006. PMID: 16815558 Review.

5

Terminal ballistics of kinase inhibitors: there are no magic bullets.

Maitland ML, Ratain MJ. Maitland ML, et al. Ann Intern Med. 2006 Nov 7;145(9):702-3. doi: 10.7326/0003-4819-145-9-200611070-00015. Ann Intern Med. 2006. PMID: 17088586 No abstract available.

6

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.

Karrison TG, Maitland ML, Stadler WM, Ratain MJ. Karrison TG, et al. Among authors: maitland ml. J Natl Cancer Inst. 2007 Oct 3;99(19):1455-61. doi: 10.1093/jnci/djm158. Epub 2007 Sep 25. J Natl Cancer Inst. 2007. PMID: 17895472

7

Interpreting P values in pharmacogenetic studies: a call for process and perspective.

Maitland ML, Ratain MJ, Cox NJ. Maitland ML, et al. J Clin Oncol. 2007 Oct 10;25(29):4513-5. doi: 10.1200/JCO.2007.12.7803. J Clin Oncol. 2007. PMID: 17925544 No abstract available.

8

Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.

Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Archer SL, et al. Among authors: maitland ml. Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H570-8. doi: 10.1152/ajpheart.01324.2007. Epub 2007 Dec 14. Am J Physiol Heart Circ Physiol. 2008. PMID: 18083891 Free article. Review.

9

Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension.

Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, Sam L, Liu Y, Husain AN, Lang RM, Ratain MJ, Lussier YA, Garcia JG. Moreno-Vinasco L, et al. Among authors: maitland ml. Physiol Genomics. 2008 Apr 22;33(2):278-91. doi: 10.1152/physiolgenomics.00169.2007. Epub 2008 Feb 26. Physiol Genomics. 2008. PMID: 18303084 Free PMC article.

10

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.

Maitland ML, Kasza KE, Karrison T, Moshier K, Sit L, Black HR, Undevia SD, Stadler WM, Elliott WJ, Ratain MJ. Maitland ML, et al. Clin Cancer Res. 2009 Oct 1;15(19):6250-7. doi: 10.1158/1078-0432.CCR-09-0058. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773379 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page